A Review of Mixed‐Effects Models of Tumor Growth and Effects of Anticancer Drug Treatment Used in Population Analysis
Top Cited Papers
Open Access
- 7 May 2014
- journal article
- review article
- Published by Wiley in CPT: Pharmacometrics & Systems Pharmacology
- Vol. 3 (5), 1-10
- https://doi.org/10.1038/psp.2014.12
Abstract
Population modeling of tumor size dynamics has recently emerged as an important tool in pharmacometric research. A series of new mixed‐effects models have been reported recently, and we present herei...Keywords
This publication has 65 references indexed in Scilit:
- PKPD Modeling of Predictors for Adverse Effects and Overall Survival in Sunitinib‐Treated Patients With GISTCPT: Pharmacometrics & Systems Pharmacology, 2013
- PKPD Modeling of VEGF, sVEGFR‐2, sVEGFR‐3, and sKIT as Predictors of Tumor Dynamics and Overall Survival Following Sunitinib Treatment in GISTCPT: Pharmacometrics & Systems Pharmacology, 2013
- A predictive pharmacokinetic–pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combinationCancer Chemotherapy and Pharmacology, 2013
- Dynamic tumor modeling of the dose–response relationship for everolimus in metastatic renal cell carcinoma using data from the phase 3 RECORD-1 trialBMC Cancer, 2012
- An Integrated Disease/Pharmacokinetic/Pharmacodynamic Model Suggests Improved Interleukin-21 Regimens Validated Prospectively for Mouse Solid CancersPLoS Computational Biology, 2011
- Predicting Outcomes of Prostate Cancer Immunotherapy by Personalized Mathematical ModelsPLOS ONE, 2010
- Nonlinear pharmacokinetics of therapeutic proteins resulting from receptor mediated endocytosisJournal of Pharmacokinetics and Pharmacodynamics, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal Of Cancer, 2009
- Efficacy of Weekly Docetaxel and Bevacizumab in Mesenchymal Chondrosarcoma: A New Theranostic Method Combining Xenografted Biopsies with a Mathematical ModelCancer Research, 2008
- Effect of Cellular Quiescence on the Success of Targeted CML TherapyPLOS ONE, 2007